Shares of Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF – Get Free Report) rose 4.4% during trading on Wednesday . The stock traded as high as $2.2872 and last traded at $2.2872. Approximately 5,200 shares were traded during mid-day trading, a decline of 72% from the average session volume of 18,475 shares. The stock had previously closed at $2.1907.
Sinopharm Group Stock Performance
The company’s 50 day moving average is $2.36 and its two-hundred day moving average is $2.48.
About Sinopharm Group
Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.
The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.
Read More
- Five stocks we like better than Sinopharm Group
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
